Gene · 1366
Papers1,866
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,866
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma. | Pathol Oncol Res | 2023 | 37621953 | PubTator, text mining | PubMed |
| Natural Retinol Analogs Potentiate the Effects of Retinal on Aged and Photodamaged Skin: Results from In Vitro to Clinical Studies. | Dermatol Ther (Heidelb) | 2023 | 37615835 | PubTator, text mining | PubMed |
| Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects. | J Clin Invest | 2023 | 37581931 | PubTator, text mining | PubMed |
| Maternal Epidermal Growth Factor Promotes Neonatal Claudin-2 Dependent Increases in Small Intestinal Calcium Permeability. | Function (Oxf) | 2023 | 37575484 | PubTator, text mining | PubMed |
| Ethanol Enhances Endothelial Rigidity by Targeting VE-Cadherin-Implications for Acute Aortic Dissection. | J Clin Med | 2023 | 37568369 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer. | World J Gastrointest Oncol | 2023 | 37546563 | PubTator, text mining | PubMed |
| Loss of Pkd1 limits susceptibility to colitis and colorectal cancer. | Oncogenesis | 2023 | 37542051 | PubTator, text mining | PubMed |
| Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM. | Development | 2023 | 37539662 | PubTator, text mining | PubMed |
| Organoid-Based Human Stomach Micro-Physiological System to Recapitulate the Dynamic Mucosal Defense Mechanism. | Adv Sci (Weinh) | 2023 | 37525340 | PubTator, text mining | PubMed |
| Immunoexpression of Claudins -3, -4 and -7 in prostate adenocarcinomas. | Rom J Morphol Embryol | 2023 | 37518873 | PubTator, text mining | PubMed |
| EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications. | Curr Issues Mol Biol | 2023 | 37504297 | PubTator, text mining | PubMed |
| Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. | Cancer Res Commun | 2023 | 37476073 | PubTator, text mining | PubMed |
| Uncovering Candidate mRNAs, Signaling Pathways and Immune Cells in Atherosclerotic Plaque and Ischemic Stroke. | Int J Gen Med | 2023 | 37465552 | PubTator, text mining | PubMed |
| How Do Microorganisms Influence the Development of Endometriosis? Participation of Genital, Intestinal and Oral Microbiota in Metabolic Regulation and Immunopathogenesis of Endometriosis. | Int J Mol Sci | 2023 | 37446108 | PubTator, text mining | PubMed |
| Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency. | Theranostics | 2023 | 37441599 | PubTator, text mining | PubMed |
| Silencing of AJAP1 expression by promoter methylation activates the Wnt/β-catenin signaling pathway to promote tumor proliferation and metastasis in salivary adenoid cystic carcinoma. | Gland Surg | 2023 | 37441023 | PubTator, text mining | PubMed |
| Analysis of the metastatic mechanism and progress in the treatment of breast cancer liver metastasis: a narrative review. | Transl Cancer Res | 2023 | 37434684 | PubTator, text mining | PubMed |
| Population dynamics of EMT elucidates the timing and distribution of phenotypic intra-tumoral heterogeneity. | iScience | 2023 | 37426354 | PubTator, text mining | PubMed |
| Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling. | NPJ Biofilms Microbiomes | 2023 | 37422471 | PubTator, text mining | PubMed |
| Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus and Staphylococcus aureus infections. | Respir Res | 2023 | 37407993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1366/papers?page=8